3,4-methylenedioxyamphetamine has been researched along with Obesity in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y | 1 |
Haines, J | 1 |
Charlton, BM | 1 |
VanderWeele, TJ | 1 |
Strain, GW | 1 |
Strain, JJ | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Obesity
Article | Year |
---|---|
Positive parenting improves multiple aspects of health and well-being in young adulthood.
Topics: Adolescent; Child; Depression; Family Relations; Feeding and Eating Disorders; Female; Health Status | 2019 |
Psychological impediments to weight loss.
Topics: Anxiety, Separation; Body Image; Family; Fear; Female; Guilt; Humans; Love; Male; Obesity; Pain; Sex | 1979 |